Abstract
Introduction People affected by leprosy are at increased risk of impairments and deformities from peripheral nerve damage. This mostly occurs if diagnosis and treatment is delayed and contributes to continued transmission within the community. Champa district of Chhattisgarh state in India is an endemic area with the highest national annual case detection and disability rates for leprosy. The Replicability Model is a system strengthening intervention implemented by the Leprosy Mission Trust India in Champa that aims to promote early diagnosis and treatment of leprosy, improve on-going management of the effects of leprosy and improve welfare for the people affected by leprosy. This protocol presents a plan to describe the overall implementation of the Replicability Model and describe the barriers and facilitators encountered in the process. We will also quantify the effect of the program on one of its key aims- early leprosy diagnosis.
Methods We have two Work Packages (WPs). In WP1, we will conduct a process evaluation. This will include three methods i) observations of replicability model implementation teams’ monthly meetings ii) key informant interviews (n=10) and interviews with stakeholders (n=30) iii) observations of key actors (n=15).Our purpose is to describe the implementation process and identify barriers and facilitators to successful implementation.
WP2 will be a quantitative study to track existing and new cases of leprosy using routinely collected data. If the intervention is successful, we expect to see an increase in cases (with a higher proportion detected at an early clinical stage) followed by a decrease in total cases.
Conclusion This study will enable us to improve and disseminate the Replicability Model by identifying factors that promote success. It will also identify its effectiveness in fulfilling one of its aims: reducing the incidence of leprosy by finding and tracking cases at an earlier stage in the disease.
Competing Interest Statement
I have read the journal's policy and three authors (Joydeepa Darlong, Karthikeyan Govindasamy and Anjali Shrivastva),of this manuscript have the following competing interests: They work for the implementing organization TLMTI
Funding Statement
This research was funded by the National Institute for Health Research (NIHR: 200132) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research will be performed in accordance with the Declaration of Helsinki for Human Research of the World Medical Association and approval has been granted by the University of Birmingham Biomedical and Scientific Research Ethics Committee (BSREC) and locally in India by The Leprosy Mission Trust India Ethics committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
joydeepa.darlong{at}leprosymission.in, karthikeyan.g{at}leprosymission.in, anjali.shrivastva{at}leprosymission.in.
r.j.lilford{at}bham.ac.uk; s.m.choudhury.1{at}bham.ac.uk; j.m.Sartori{at}bham.ac.uk; s.i.watson{at}bham.ac.uk; u.ilozumba{at}bham.ac.uk
f.e.griffiths{at}warwick.ac.uk
Data Availability
No datasets were generated or analyzed during the current study. All relevant data from this study will be made available upon study completion.
